Evidence map›Paper›PMID 26509441›Full record

ArticlePloS one2015

The Virological and Immunological Characteristics of the HIV-1-Infected Population in Brazil: From Initial Diagnosis to Impact of Antiretroviral Use.

Ricardo Sobhie Diaz, Lilian A Inocêncio, Maria Cecilia Araripe Sucupira, Anderson Alvarenga Pereira, James Hunter, João Eduardo Ferreira, Luciano V Araújo, Denise F C Souza, Ester Cerdeira Sabino

Abstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Depression and Anxiety as Risk Factors for Delayed Care-Seeking Behavior in Human Immunodeficiency Virus-Infected Individuals in South Africa.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2018
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Trends and predictors of HIV-1 acquired drug resistance in Minas Gerais, Brazil: 2002-2012.The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Ricardo Sobhie DiazFederal University of São Paulo, São Paulo, Brazil.
Lilian A InocêncioFederal University of São Paulo, São Paulo, Brazil; Brazilian STD/AIDS and Viruses Hepatitis Department, Ministry of Health, Brasilia, DF, Brazil.
Maria Cecilia Araripe SucupiraFederal University of São Paulo, São Paulo, Brazil.
Anderson Alvarenga PereiraBrazilian STD/AIDS and Viruses Hepatitis Department, Ministry of Health, Brasilia, DF, Brazil.
James HunterFederal University of São Paulo, São Paulo, Brazil.
João Eduardo FerreiraUniversity of Sao Paulo, Sao Paulo, Brazil.
Luciano V AraújoUniversity of Sao Paulo, Sao Paulo, Brazil.
Denise F C SouzaBrazilian STD/AIDS and Viruses Hepatitis Department, Ministry of Health, Brasilia, DF, Brazil.
Ester Cerdeira SabinoUniversity of Sao Paulo, Sao Paulo, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundImmunological and virological status of HIV-infected individuals entering the Brazilian public system over time was analyzed. We evaluated the impact of ART on virological, immunological and antiretroviral resistance over time.

methodsCD4+ T cell counts, viral loads and genotypes from patients over 13 years old from 2001-2011 were analyzed according to demographic data. We compared groups using parametric t-tests and linear regression analysis in the R statistical software language.

resultsMean baseline CD4+ T cell counts varied from 348 (2003) to 389 (2009) and was higher among women (p = 1.1 x 10(-8)), lower in older patients (p< 1 x 10(-8)) and lower in less developed regions (p = 1.864 x 10(-5)). Percentage of treated patients with undetectable viral loads increased linearly from 46% (2001) to 77% (2011), was lower among women (p = 2.851 x 10(-6)), younger ages (p = 1 x 10(-3)), and in less developed regions (p = 1.782 x 10(-4)). NRTI acquired resistance was 86% in 2001-3 and decreased over time. NNRTI resistance increased from 2001-3(50%) to 2006-9 (60%), PI resistance decreased from 2001-3 (60%) to 2009 (40%), and 3-class resistance was stable over time around 25%. Subtype prevalence comprised B (75.3%), B/F recombinants (12.2%), C (5.7%), F (5.3%) and B/C recombinants (1.5%), with regional variations. Three-class resistance was 26.5% among Bs, 22.4% among Fs and 17.2% among Cs.

conclusionsHIV diagnosis occurs late, especially among elderly Brazilians. Younger individuals need special attention due to poor virological response to treatment. Antiretroviral Resistance profile is subtype related.

Indexed as

Antiretroviral Therapy, Highly ActiveAdolescentAdultBrazilCD4 Lymphocyte CountDrug Resistance, ViralFemaleHIV InfectionsHumansLimit of DetectionMaleMiddle AgedViral LoadYoung Adult

Identifiers

PMID26509441
PMCPMC4624810

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.